Skip to content
sellWeak

Kevin Patrick O'Brien sold $1,737 of HYFM

Chief Financial Officer at HYDROFARM HOLDINGS GROUP, INC.. 1,150 shares at an average of $1.51, traded Jan 6, 2026, filed Jan 8, 2026.

Warning score
22
Value
$1,737
1,150 shares
Holdings after
13,222
-8% from before
From 52-week low
+44%
low $1.51, close $2.18
From 52-week high
-69%
high $7.00, as of Jan 6, 2026

Score components

  • Role
    CFO
    +22
  • Trade size
    $2k at market
    0
  • Share of holdings sold
    Sold 8.0% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -25.3%, 3m -50.0%, 6m -57.2%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

HYFMOct 13, 2026 · close 0.78
Since filing Jan 8, 2026: -59.8%SPY +13.7% · excess -73.5%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001735272-26-000002, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jan 6, 2026SOpen-market sale
Common Stock, $0.0001 par value per share
-1,150$1.51$1,73713,222Jan 8, 2026

Related signals

Other insiders at HYDROFARM HOLDINGS GROUP, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
15Weak
HYFMsell
HYDROFARM HOLDINGS GROUP, INC.
Melisa Denis
director
$5,637
2,995 shares
-5%
53Moderate
HYFMbuy
HYDROFARM HOLDINGS GROUP, INC.
William Douglas Toler
CEO and Chairman of the Board
$50k
100,000 shares
+6%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kevin Patrick O'Brien sold $1,737 of HYFM | InsiderTell